Clik here to view.
First Patient is Enrolled in Global STEMTRA Trial for Traumatic Brain Injury...
MOUNTAIN VIEW, Calif. & TOKYO SanBio Co., Ltd., a scientific leader in regenerative medicine for neurological disorders, today announced that the first patient in Japan was enrolled in the...
View ArticleClik here to view.
Intralink-Spine’s Réjuve Treatment Eliminates Low Back Pain
LEXINGTON, Ky. With the continuation of extremely positive clinical results from its early safety and feasibility study in Malaysia, Intralink-Spine, Inc. (ILS) believes the Réjuve System is going...
View ArticleClik here to view.
Astellas Reports First Half FY2016 Financial Results, Revises Fiscal Year...
TOKYO Astellas Pharma Inc. (TOKYO:4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced financial results for the first six months of fiscal year 2016 ending March 31, 2017...
View ArticleClik here to view.
Takeda Reports First Half FY2016 Results and Raises Full Year Profit Guidance
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Strong first half results led by Growth Drivers Underlying Revenue grew +7.4%, led by a +15.3% increase of Takeda’s Growth...
View ArticleClik here to view.
2016年度上期（4‐9月期）の連結業績について当期利益およびEPSの年間予想、実質的なコア・アーニングスのマネジメントガイダンスを上方修正
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 （東証：4502）： タケダ成長ドライバーが力強い上期実績を牽引 売上収益の実質的な成長は、タケダ成長ドライバー（消化器系疾患領域、オンコロジー、中枢神経系疾患領域、新興国事業）の＋15.3％の伸長により、対前年同期＋7.4％を達成。財務ベースでは、為替影響（△8.6ポイント）や事業等の売却影響（△4.7ポイント）により対前年同期△5.9％...
View ArticleClik here to view.
Acucela Issues Notice of Listing Approval of Kubota Pharmaceutical Holdings
SEATTLE Acucela Inc. (Tokyo:4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
フレックスグローバルが世界的な総合eTMFソリューションをバイエルに提供
英アマーシャム & 米ペンシルバニア州マルバーン （ビジネスワイヤ） — 電子治験マスターファイル（eTMF）技術とTMFサービスをライフサイエンス業界に提供するパイオニア的専門企業のフレックスグローバルは、市場をリードする当社のeTMFであるPhlexEviewが、バイエルの製薬部門向けeTMFソリューションとして成功していることを発表します。...
View ArticleClik here to view.
Hoya Reports Second Quarter Results
TOKYO Hoya Corporation (TOKYO: 7741) today announced financial results for the second quarter ended September 30, 2016. During the quarter, revenue of the HOYA Group decreased 11.8% year on year, to...
View ArticleClik here to view.
World-Leading Experts Collaborate at Cochlear’s Global Research Symposium
SYDNEY There are 360 million people living with disabling hearing loss worldwide and this figure is set to increase significantly to 1.2 billion by 2050.,12 To prepare for the expanding needs of...
View ArticleClik here to view.
Vyome Biosciences Administers First In-human Dose of VB 1953 in U.S. Phase 1...
NEW DELHI Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announced that it...
View ArticleClik here to view.
武田公布2016财年上半年业绩并提高全年利润指引
日本大阪 (美国商业资讯)–武田药品工业株式会社(TOKYO:4502)： 强劲的上半年业绩得益于增长引擎 得益于武田增长引擎（胃肠药、肿瘤药、CNS和新兴市场）+15.3%的增长，基础营收增长+7.4%。 由于不利的汇率影响（-8.6个百分点）和剥离影响（-4.7个百分点），报告的营收下降5.9%。...
View ArticleClik here to view.
AtriCure Announces Approval for the cryoICE™ Platform in Japan
MASON, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received approval...
View ArticleClik here to view.
Mannatech的在华商业计划简体中文字幕短片现已在美国商业资讯网站发布
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 中国广州 (美国商业资讯)–Mannatech®, Incorporated (Nasdaq:MTEX)的一部简体中文字幕短片现已在美国商业资讯网站发布，Mannatech的首席执行官兼总裁Alfredo “Al”...
View ArticleClik here to view.
Takeda Donates 1 Billion Yen as an Exclusive Partner to the United Nations...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced that Takeda will exclusively support “Global Measles Vaccination for Children” by the United Nations Foundation’s...
View ArticleClik here to view.
Takeda: CSR Programs Focusing on Maternal and Child Health
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced that the company will implement three CSR programs focusing on solutions to maternal and child healthcare problems in...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
Pfizer’s Prevenar 13® Receives Approval For Use in Infants and Children in China
NEW YORK Pfizer China announced today that it has received approval from the Chinese Food and Drug Administration (CFDA) to market its pneumococcal 13-valent conjugate vaccine, Prevenar 13®, in...
View ArticleClik here to view.
エイトリキュアがcryoICE™プラットフォームの日本での承認を発表
米オハイオ州メーソン （ビジネスワイヤ） — 心房細動（Afib）治療と左心耳（LAA）管理における一流イノベーター企業のエイトリキュア（Nasdaq: ATRC）は本日、cryoICE™プラットフォームおよびCRYO2冷凍アブレーションプローブの承認を厚生労働省より取得したと発表しました。承認により、これらの製品が日本市場で初めて提供可能になります。...
View ArticleClik here to view.
Custom PCR Master Mixes Ship in 10 Days with New Promega cGMP PCR Kit for...
MADISON, Wis. Now available, the Promega PCR Optimization Kit allows customers to rapidly define their own unique PCR master mix manufactured under cGMP for research or clinical use. The user’s...
View Article